Please use this identifier to cite or link to this item:
Author(s): A. C. Abreu
D. Paulet
A. Coqueiro
J. Malheiro
A. Borges
M. J. Saavedra
Y. H. Choi
M. Simões
Title: Antibiotic adjuvants from Buxus sempervirens to promote effective treatment of drug-resistant Staphylococcus aureus biofilms
Issue Date: 2016
Abstract: Plants have been long scrutinized in the quest for new antibiotics, but no strong antibiotic molecule was ever found. Evidence exists that most phytochemicals have a regulatory or adjuvant effect on other antibacterial compounds, thus promoting a greater therapeutic effect. The current study assessed twenty-eight plants from different families for their antibacterial activity and as adjuvants in antibiotic therapy against Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA). Eucalyptus globulus, Castanea sativa, Agrimonia eupatoria and Fraxinus excelsior methanolic extracts showed antibacterial activity with minimal inhibitory concentrations (MICs) of 0.125-0.5, 0.5-1.0, 1.0-2.0, and 2.0-4.0 g L (1), respectively. Non-antibacterial plants were assessed in combination with ampicillin, oxacillin, ciprofloxacin, erythromycin and tetracycline by a modified disc diffusion test. Methanolic extracts of Acacia dealbata, Prunus spp. plants, Centaurea nigra, Eupatorium cannabium and Buxus sempervirens showed a potentiating effect mostly of ciprofloxacin, erythromycin and tetracycline. B. sempervirens was selected for its potentiating activity and applied against S. aureus biofilms. B. sempervirens (1 g L-1) was able to cause an 88% reduction of S. aureus within 1 h exposure. Further phytochemical investigation of B. sempervirens allowed to identify betulinic acid as a major component, together with other triterpenoids. Betulinic acid and other common terpernoids - lupeol, betulin, hederagenin, ursolic acid and oleanolic acid, were tested for antibacterial and antibiotic-potentiating activities. Among the tested compounds, oleanolic acid and ursolic acid - were highlighted, showing MIC of 62.5 and 15.6 mg L-1, respectively, against S. aureus. Additionally, oleanolic acid showed synergism when combined with tetracycline and erythromycin and caused biofilm reductions of 70, 81 and 85% when applied at 1/2 MIC, MIC and 2 x MIC, respectively.
Subject: Ciências da Saúde, Ciências médicas e da saúde, Ciências da engenharia e tecnologias
Health sciences, Medical and Health sciences, Engineering and technology
Scientific areas: Ciências da engenharia e tecnologias
Engineering and technology
Ciências médicas e da saúde
Medical and Health sciences
Related Information: info:eu-repo/grantAgreement/FCT - Fundação para a Ciência e a Tecnologia/Projetos Estratégicos/UID/EQU/00511/2013 - POCI-01-0145-FEDER-006939/Laboratório de Engenharia de Processos, Ambiente, Biotecnologia e Energia/LEPABE
Document Type: Artigo em Revista Científica Internacional
Rights: openAccess
Appears in Collections:FEUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
181642.pdfArtigo original publicado1.38 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.